PGY2 Transplant Pharmacy Residency Overview

Mission Statement

The PGY2 Solid Organ Transplant pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available. Pharmacists completing this residency will be competent to work side-by-side with a variety of medical team members, and will provide evidence-based, best practice, patient-centered care to kidney, pancreas, liver, heart and lung transplant recipients.

Program Overview

Tampa General Hospital ranks as one of the busiest transplant programs in the US, with over 350 kidney and kidney/pancreas transplants, 150 liver transplants, 40 heart transplants, and 40 lung transplants performed annually. Additionally, 8 – 10 pediatric kidney transplants are performed each year. The PGY2 solid organ transplant pharmacy resident will be an integral part of the health care team for each transplant service, providing comprehensive pharmaceutical care services including pre-transplant evaluations, initial transplant consults, pharmacokinetic analysis, drug information, intensive drug monitoring, discharge education to patients on service and discharge transitions of care services. The resident will also have the opportunity to enhance their precepting skills while serving as a primary preceptor for both rotating students and PGY1 residents. In the ambulatory care setting, the pharmacy resident will gain experience in managing a variety of chronic disease states through time spent with abdominal and cardiothoracic transplant clinics. The PGY2 solid organ transplant preceptors provide a comprehensive educational environment for the transplant resident. These preceptors are integral parts of the various transplant teams, which include a variety of surgical and medical teams focused on providing optimal comprehensive care to newly transplanted and re-admitted transplant recipients. They have a proven commitment to training pharmacists in the management of transplant recipients. Their backgrounds represent a diverse mix of experiences and training:

  • Specialty residency training 

  • Pharmacy practice residency training

  • Board certification

In addition to a focus on direct patient care, preceptors are involved in scholarly activities such as journal publication, textbook publication, scientific journal peer review, clinical research, and platform and poster presentations at various state and national meetings. These practitioners are also actively involved with local, state, national and international professional organizations (e.g., American Society of Transplantation, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Vizient and International Society of Heart and Lung Transplantation).


Residents completing this residency program will have a variety of teaching responsibilities throughout the year. Formal teaching opportunities include formal grand rounds presentations to pharmacy staff, student topic discussions, morning report to medical residents, and transplant grand rounds to the transplant department.

Academic teaching opportunities focusing on transplant pharmacotherapy are available through the University of South Florida with over 10 hours of didactic opportunities available. Finally, informal opportunities are numerous, including nursing services and patient/caregiver medication education and counseling.

Residents will serve as co-preceptors for pharmacy students on rotation as well as co-precept any PGY1 residents on transplant rotations.

Scholarly Activity 

The PGY2 solid organ transplant resident will become proficient in completing clinical research projects designed to advance transplant pharmacy knowledge and practice. Pharmacy residents will lead and complete one major research project, and garner IRB approval for a second research project for the next incoming resident. The pharmacy resident will submit abstract(s) to the American Transplant Congress and/or the International Society for Heart and Lung Transplant meeting for presentation (if selected), and the research project will be written and submitted for publication. In addition to these research projects, quality improvement projects will be completed in conjunction with a transplant pharmacotherapy specialist throughout the year as needs arise. 

Residents with a specific interest in publication will have the opportunity to complete and submit a paper for publication during the residency year. Examples of past resident’s publications include review articles as well as publication of major research projects. Finally, residents may present their projects at the following meetings:

  • Vizient Annual Meeting
  • Florida Residency Conference (FRC)
  • American Transplant Congress Conference (if accepted)
  • International Society of Heart and Lung Transplant (if accepted)

Staffing Responsibilities 

Residents are trained to independently function as a decentralized, unit-based clinical pharmacist supporting both the pharmacotherapy consult and pharmacy practice service at TGH. The PGY2 solid organ transplant resident will complete their staffing responsibilities on the transplant unit and cardiovascular unit every 4th weekend.

The role and responsibilities of a decentralized, unit-based clinical pharmacist is to support all pharmaceutical services for the patient care area assigned and may include but is not limited to the following:

  • Verifying pharmacy orders

  • Supporting the pharmacotherapy consult service including pharmacokinetic dosing of medication therapy to include, but not limited to aminoglycosides, vancomycin, warfarin, etc.

  • Writing and monitoring orders for TPN.

  • Supporting the medication reconciliation service

  • Triaging and resolving medication problems

  • Responding to code blue team

  • Discharge medication reconciliation reviews

  • Supervising and overseeing pharmacy technicians and students

All residents work one major (Thanksgiving, Christmas or New Year's Day) and one minor (Labor Day and Memorial Day) holiday throughout the year.

Program Sites

  • The resident will complete various clinical rotations and activities at Tampa General Hospital.

  • Ambulatory care rotations are conducted at Tampa General Medical Group Clinic and USF Advanced Lung Disease Clinic.

  • Academic teaching experiences may be conducted at the University of South Florida College of Pharmacy.

Concentrated Experiences

 Table of Transplant Residency Concentrated Experiences

Core Rotations (10 Months):

Elective Rotations (2 Months):

Pharmacy Orientation (4 weeks)

Transplant Infectious Diseases

Inpatient Kidney Transplant (2 months)

Advanced HF/MCS

Inpatient Liver Transplant (2 months)

Surgical/Trauma ICU

Inpatient Heart Transplant (2 months)

Concentrated Ambulatory Care

Inpatient Lung Transplant (2 months)

Advanced Transplant Elective


Longitudinal Experiences

  • Major research projects

  • Transplant Ambulatory Care

  • Transplant and pharmacy administration

  • Staffing: decentralized, unit-based pharmacist (refer to Staffing Responsibilities)
  • Teaching: Pharmacy/Physician/Student teaching.

Click to see the preceptors page for bios and information

Program Specifics

Table of Program Specifics

Residency Program PGY2 Transplant Residency
ASHP Program Code 33008
NMS Code 612276
Accreditation Status Accredited
Duration/Type 12 months
Number of Positions 1
Application Deadline January 1st (Please note this program will participate in PhORCAS)
Starting Date July 1
Estimated Stipend $54,100
Interview Required Yes
Training Site Hospital
Owner/Affiliate Private
Model Type(s) Teaching
Tax Status Nonprofit
Professional Staff 185 pharmacists
Non-professional Staff 200 non-pharmacist staff
Total Beds (Licensed) 981 total beds 
Average Daily Census 907


  • Competitive salary
  • Medical insurance (e.g. health, dental)
  • Sick leave
  • Paid vacation
  • Retirement plan contributions
  • Health and Wellness Center
  • Professional travel reimbursement
  • Lab coats
  • Resident office
  • Resident computer
  • Cell phone stipend (pending eligible carrier)
  • ACLS certification


Please address all correspondence to PGY2 Transplant Residency Director:

Angela T. Logan, PharmD, BCPS, BCTXP
PGY2 Solid Organ Transplant Residency Program Director
Solid Organ Transplant Pharmacotherapy Specialist
Tampa General Hospital
813-844-3534 (office)
813-844-4062 (fax)